Q4 2026 Bharat Parenterals Ltd Earnings Call Transcript

May 19, 2026 / 09:30 AM GMT

Release Date Price: ₹1248.15 (-1.45%)

Transcript

Key Points

Positve

Bharat Parenterals Ltd (BOM:541096) achieved a significant EBITDA growth of 485% in FY26, reaching 15.8 crores compared to 2.7 crores last year.
Inoxyl, the company's complex generics subsidiary, experienced a remarkable revenue growth of 174.1%, contributing significantly to the overall performance.
Varanium Healthcare, the branded domestic business, turned profitable for the first time with a revenue growth of 13.7%.
The company successfully reduced its finance costs by 28% and other expenses by 40% year-on-year.
Bharat Parenterals Ltd (BOM:541096) received US FDA and EUGMP clearances for its facilities, positioning it for commercial supply to the US and select European markets.

Negative

The standalone revenue for Bharat Parenterals Ltd (BOM:541096) declined by 23% due to deferred export tenders and production line upgrades.
The company's consolidated PAT narrowed to 27.3 crores from 43.7 crores, indicating a decrease in profitability.
There were delays in export orders and disruptions due to major audit events, impacting the standalone business growth.
Varanium Biolife Sciences, a complex injectable platform, is still under construction and pre-revenue, with commercialization expected only by FY29.
Guidance for FY27 was downgraded across segments, reflecting a cautious outlook due to previous unmet expectations and ongoing structural changes.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

BATP.BO - Bharat Parenterals Ltd
Q4 2026 Bharat Parenterals Ltd Earnings Call
May 19, 2026 / 09:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, good day and welcome to the Bharat Parenteral Q4 and FY26 Earnings Conference Call hosted by Philip Capital Private Client Group.

As a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the conference call, please signal an operator by pressing then 0 on your touchstone phone.

I now hand the conference call over to Mr. Detal Shah from Philip Capital BCG.

Thank you and over to you, sir.

--------------------------------------------------------------------------------
Unidentified_2 [2]
------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.